Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Johnson & Johnson ramps up Tylenol production as demand surges

Published 03/13/2020, 01:18 PM
Updated 03/13/2020, 01:21 PM
Johnson & Johnson ramps up Tylenol production as demand surges

By Saumya Joseph

(Reuters) - Johnson & Johnson is seeing a spike in demand for its Tylenol over-the-counter pain killer and other self-care products, the company said on Friday, as the global spread of the coronavirus prompts people to stock up on essentials.

The company, which also makes Band-Aid and Listerine mouth wash, said it was shipping its stock in a "controlled manner" and that its manufacturing sites had ramped up production to ensure supply.

J&J said it did not anticipate a shortage of Tylenol, a commonly used drug for headache and fever, even though the drug "may have temporarily run out of stock at one location".

Fears around shortages of some drugs emerged after the coronavirus outbreak wreaked havoc on supply chains and were amplified last week after India, the world's main supplier of generic drugs, restricted the export of some ingredients as well as medicines including paracetamol, known as Tylenol in the United States.

J&J also said it was taking all possible measures to maximize the availability of its consumer products.

The coronavirus, which originated in Wuhan, China last year, has spread to more than 100 countries and killed more than 5,000 people worldwide, sparking a rush for everyday items ranging from toilet paper to packaged foods.

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) Inc and supermarket chain Kroger (NYSE:KR) Co on Thursday placed purchase limits to stabilize inventory.

Kroger placed a limit on the number of cold, flu and sanitary products per order, while Walgreens said it was limiting disinfectant wipes and cleaners, face masks, hand sanitizers, thermometers and gloves to four each per customer.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company also said majority of its global medical device manufacturing was running at or near normal capacity, and that it does not expect the outbreak to cause any disruptions to its supply of medicines.

J&J said it had business continuity plans in place across its global supply chain network, including maintaining inventory at distribution centers away from high-risk areas and said it was monitoring demand and supply levels.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.